Skip to main content
Top
Published in: BMC Gastroenterology 1/2009

Open Access 01-12-2009 | Research article

Increasing prevalence and high incidence of celiac disease in elderly people: A population-based study

Authors: Anitta Vilppula, Katri Kaukinen, Liisa Luostarinen, Ilkka Krekelä, Heikki Patrikainen, Raisa Valve, Markku Mäki, Pekka Collin

Published in: BMC Gastroenterology | Issue 1/2009

Login to get access

Abstract

Background

Celiac disease may emerge at any age, but little is known of its appearance in elderly people. We evaluated the prevalence of the condition in individuals over 55 years of age, and determined the incidence of biopsy-proven celiac disease (CDb) and celiac disease including seropositive subjects for anti-tissue transglutaminase antibodies (CDb+s).

Methods

The study based on prevalence figures in 2815 randomly selected subjects who had undergone a clinical examination and serologic screening for celiac disease in 2002. A second screening in the same population was carried out in 2005, comprising now 2216 individuals. Positive tissue transglutaminase antibodies were confirmed with small bowel biopsy.

Results

Within three years the prevalence of CDb increased from 2.13 to 2.34%, and that of CDb+s from 2.45 to 2.70%. Five new cases were found among patients previously seronegative; two had minor abdominal symptoms and three were asymptomatic. The incidence of celiac disease in 2002–2005 was 0.23%, giving an annual incidence of 0.08% in this population.

Conclusion

The prevalence of celiac disease was high in elderly people, but the symptoms were subtle. Repeated screening detected five biopsy-proven cases in three years, indicating that the disorder may develop even in the elderly. Increased alertness to the disorder is therefore warranted.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Hopper AD, Hadjivassiliou M, Hurlstone DP, et al: What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol. 2008, 6: 314-320. 10.1016/j.cgh.2007.12.008.CrossRefPubMed Hopper AD, Hadjivassiliou M, Hurlstone DP, et al: What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol. 2008, 6: 314-320. 10.1016/j.cgh.2007.12.008.CrossRefPubMed
3.
go back to reference Vilppula A, Collin P, Mäki M, et al: Undetected coeliac disease in the elderly. A biopsy-proven population-based study. Dig Liver Dis. 2008, 40: 809-813. 10.1016/j.dld.2008.03.013.CrossRefPubMed Vilppula A, Collin P, Mäki M, et al: Undetected coeliac disease in the elderly. A biopsy-proven population-based study. Dig Liver Dis. 2008, 40: 809-813. 10.1016/j.dld.2008.03.013.CrossRefPubMed
5.
go back to reference United European Gastroenterology: When is a coeliac a coeliac. Report of a working group of the United European Gastroenterology Week in Amsterdam 2001. Eur J Gastroenterol Hepatol. 2001, 13: 1123-1128. 10.1097/00042737-200109000-00023.CrossRef United European Gastroenterology: When is a coeliac a coeliac. Report of a working group of the United European Gastroenterology Week in Amsterdam 2001. Eur J Gastroenterol Hepatol. 2001, 13: 1123-1128. 10.1097/00042737-200109000-00023.CrossRef
6.
go back to reference Sulkanen S, Halttunen T, Laurila K, et al: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998, 115: 1322-1328. 10.1016/S0016-5085(98)70008-3.CrossRefPubMed Sulkanen S, Halttunen T, Laurila K, et al: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 1998, 115: 1322-1328. 10.1016/S0016-5085(98)70008-3.CrossRefPubMed
7.
go back to reference Mäki M, Mustalahti K, Kokkonen J, et al: Prevalence of celiac disease among children in Finland. N Engl J Med. 2003, 348: 2517-2524. 10.1056/NEJMoa021687.CrossRefPubMed Mäki M, Mustalahti K, Kokkonen J, et al: Prevalence of celiac disease among children in Finland. N Engl J Med. 2003, 348: 2517-2524. 10.1056/NEJMoa021687.CrossRefPubMed
8.
go back to reference Lohi S, Mustalahti K, Kaukinen K, et al: Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007, 26: 1217-1225.CrossRefPubMed Lohi S, Mustalahti K, Kaukinen K, et al: Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007, 26: 1217-1225.CrossRefPubMed
9.
go back to reference Viljamaa M, Kaukinen K, Pukkala E, et al: Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis. 2006, 38: 374-380. 10.1016/j.dld.2006.03.002.CrossRefPubMed Viljamaa M, Kaukinen K, Pukkala E, et al: Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis. 2006, 38: 374-380. 10.1016/j.dld.2006.03.002.CrossRefPubMed
10.
go back to reference Salmi TT, Collin P, Jarvinen O, et al: Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther. 2006, 24: 541-552. 10.1111/j.1365-2036.2006.02997.x.CrossRefPubMed Salmi TT, Collin P, Jarvinen O, et al: Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther. 2006, 24: 541-552. 10.1111/j.1365-2036.2006.02997.x.CrossRefPubMed
11.
go back to reference Kurppa K, Collin P, Viljamaa M, et al: Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology. 2009, 136: 816-823. 10.1053/j.gastro.2008.11.040.CrossRefPubMed Kurppa K, Collin P, Viljamaa M, et al: Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology. 2009, 136: 816-823. 10.1053/j.gastro.2008.11.040.CrossRefPubMed
12.
go back to reference Salmi TT, Collin P, Korponay-Szabo IR, et al: Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006, 55: 1746-1753. 10.1136/gut.2005.071514.CrossRefPubMedPubMedCentral Salmi TT, Collin P, Korponay-Szabo IR, et al: Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006, 55: 1746-1753. 10.1136/gut.2005.071514.CrossRefPubMedPubMedCentral
13.
go back to reference Murray JA, Van Dyke C, Plevak MF, et al: Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol. 2003, 1: 19-27. 10.1053/jcgh.2003.50004.CrossRefPubMed Murray JA, Van Dyke C, Plevak MF, et al: Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol. 2003, 1: 19-27. 10.1053/jcgh.2003.50004.CrossRefPubMed
15.
go back to reference Collin P, Huhtala H, Virta L, et al: Diagnosis of celiac disease in clinical practise. Physician's alertness to the condition essential. J Clin Gastroenterol. 2007, 41: 152-156. 10.1097/01.mcg.0000212618.12455.a8.CrossRefPubMed Collin P, Huhtala H, Virta L, et al: Diagnosis of celiac disease in clinical practise. Physician's alertness to the condition essential. J Clin Gastroenterol. 2007, 41: 152-156. 10.1097/01.mcg.0000212618.12455.a8.CrossRefPubMed
16.
go back to reference Biagi F, Campanella J, Bianchi PI, et al: The incidence of coeliac disease in adult first-degree relatives. Dig Liver Dis. 2008, 40: 97-100. 10.1016/j.dld.2007.10.004.CrossRefPubMed Biagi F, Campanella J, Bianchi PI, et al: The incidence of coeliac disease in adult first-degree relatives. Dig Liver Dis. 2008, 40: 97-100. 10.1016/j.dld.2007.10.004.CrossRefPubMed
17.
go back to reference Högberg L, Fälth-Magnusson K, Grodzinsky E, et al: Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol. 2003, 38: 61-65. 10.1080/00365520310000456.CrossRefPubMed Högberg L, Fälth-Magnusson K, Grodzinsky E, et al: Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol. 2003, 38: 61-65. 10.1080/00365520310000456.CrossRefPubMed
18.
go back to reference Niveloni S, Pedreira S, Sugai E, et al: The natural history of gluten sensitivity: report of two new celiac disease patients resulting from long-term follow-up of nonatrophic, first-degree relatives. Am J Gastroenterol. 2000, 95: 463-468. 10.1111/j.1572-0241.2000.01769.x.CrossRefPubMed Niveloni S, Pedreira S, Sugai E, et al: The natural history of gluten sensitivity: report of two new celiac disease patients resulting from long-term follow-up of nonatrophic, first-degree relatives. Am J Gastroenterol. 2000, 95: 463-468. 10.1111/j.1572-0241.2000.01769.x.CrossRefPubMed
19.
go back to reference Freeman HJ: Clinical spectrum of biopsy-defined celiac disease in the elderly. Can J Gastroenterol. 1995, 9: 42-46.CrossRef Freeman HJ: Clinical spectrum of biopsy-defined celiac disease in the elderly. Can J Gastroenterol. 1995, 9: 42-46.CrossRef
21.
go back to reference Lurie Y, Landau DA, Pfeffer J, et al: Celiac disease diagnosed in the elderly. J Clin Gastroenterol. 2008, 42: 59-61. 10.1097/01.mcg.0000247995.12087.7b.CrossRefPubMed Lurie Y, Landau DA, Pfeffer J, et al: Celiac disease diagnosed in the elderly. J Clin Gastroenterol. 2008, 42: 59-61. 10.1097/01.mcg.0000247995.12087.7b.CrossRefPubMed
Metadata
Title
Increasing prevalence and high incidence of celiac disease in elderly people: A population-based study
Authors
Anitta Vilppula
Katri Kaukinen
Liisa Luostarinen
Ilkka Krekelä
Heikki Patrikainen
Raisa Valve
Markku Mäki
Pekka Collin
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2009
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-9-49

Other articles of this Issue 1/2009

BMC Gastroenterology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine